Literature DB >> 18353867

TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation.

Dong-Myung Shin1, Ju-Hong Jeon, Chai-Wan Kim, Sung-Yup Cho, Hye-Jin Lee, Gi-Yong Jang, Eui Man Jeong, Dong-Sup Lee, Ja-Heon Kang, Gerry Melino, Sang-Chul Park, In-Gyu Kim.   

Abstract

Transglutaminase 2 (TGase2) is a ubiquitously expressed enzyme that catalyzes irreversible post-translational modification of protein, forming cross-linked protein aggregates. We previously reported that intracellular TGase2 is activated by oxidative stress. To elucidate the functional role of TGase2 activation in cells under the oxidatively stressed condition, we identified the mediator that activates TGase2. In this study, we showed that low levels of oxidative stress trigger the release of TGFbeta, which subsequently activates TGase2 through the nuclear translocation of Smad3. Analysis of substrate proteins reveals that TGase2-mediated protein modification results in a decrease of protein solubility and a collapse of intermediate filament network, which leads to aggregation of proteins. We confirm these results using lens tissues from TGase2-deficient mice. Among several antioxidants tried, only N-acetylcysteine effectively inhibits TGFbeta-mediated activation of TGase2. These results indicate that TGFbeta mediates oxidative stress-induced protein aggregation through activation of TGase2 and suggest that the formation of protein aggregation may not be a passive process of self-assembly of oxidatively damaged proteins but may be an active cellular response to oxidative stress. Therefore, TGFbeta-TGase2 pathway may have implications for both the pathogenesis of age-related degenerative diseases and the development of pharmaceutics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353867     DOI: 10.1096/fj.07-095455

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  28 in total

1.  Transglutaminase 2 inhibits apoptosis induced by calcium- overload through down-regulation of Bax.

Authors:  Sung-Yup Cho; Jin-Haeng Lee; Han-Dong Bae; Eui Man Jeong; Gi-Yong Jang; Chai-Wan Kim; Dong-Myung Shin; Ju-Hong Jeon; In-Gyu Kim
Journal:  Exp Mol Med       Date:  2010-09-30       Impact factor: 8.718

2.  Keratin 8 phosphorylation regulates its transamidation and hepatocyte Mallory-Denk body formation.

Authors:  Raymond Kwan; Shinichiro Hanada; Masaru Harada; Pavel Strnad; Daniel H Li; M Bishr Omary
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

3.  Doxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell death.

Authors:  Sung-Yup Cho; Eui Man Jeong; Jin-Haeng Lee; Hyo-Jun Kim; Jisun Lim; Chai-Wan Kim; Dong-Myung Shin; Ju-Hong Jeon; Kyungho Choi; In-Gyu Kim
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

4.  Transglutaminase 2 and its role in pulmonary fibrosis.

Authors:  Keith C Olsen; Ramil E Sapinoro; R M Kottmann; Ajit A Kulkarni; Siiri E Iismaa; Gail V W Johnson; Thomas H Thatcher; Richard P Phipps; Patricia J Sime
Journal:  Am J Respir Crit Care Med       Date:  2011-06-23       Impact factor: 21.405

Review 5.  Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?

Authors:  Corinne Abbadie; Olivier Pluquet; Albin Pourtier
Journal:  Cell Mol Life Sci       Date:  2017-07-13       Impact factor: 9.261

6.  Transglutaminase 2 promotes both caspase-dependent and caspase-independent apoptotic cell death via the calpain/Bax protein signaling pathway.

Authors:  Je-Ok Yoo; Young-Cheol Lim; Young-Myeong Kim; Kwon-Soo Ha
Journal:  J Biol Chem       Date:  2012-03-14       Impact factor: 5.157

Review 7.  Transglutaminse 2 and EGGL, the protein cross-link formed by transglutaminse 2, as therapeutic targets for disabilities of old age.

Authors:  William Bains
Journal:  Rejuvenation Res       Date:  2013-12       Impact factor: 4.663

8.  A combined proteomic and transcriptomic approach shows diverging molecular mechanisms in thoracic aortic aneurysm development in patients with tricuspid- and bicuspid aortic valve.

Authors:  Sanela Kjellqvist; Shohreh Maleki; Therese Olsson; Maggy Chwastyniak; Rui Miguel Mamede Branca; Janne Lehtiö; Florence Pinet; Anders Franco-Cereceda; Per Eriksson
Journal:  Mol Cell Proteomics       Date:  2012-11-26       Impact factor: 5.911

9.  The redox state of transglutaminase 2 controls arterial remodeling.

Authors:  Jeroen van den Akker; Ed VanBavel; Remon van Geel; Hanke L Matlung; Bilge Guvenc Tuna; George M C Janssen; Peter A van Veelen; Wilbert C Boelens; Jo G R De Mey; Erik N T P Bakker
Journal:  PLoS One       Date:  2011-08-25       Impact factor: 3.240

10.  Transglutaminase-2 interaction with heparin: identification of a heparin binding site that regulates cell adhesion to fibronectin-transglutaminase-2 matrix.

Authors:  Hugues Lortat-Jacob; Izhar Burhan; Alessandra Scarpellini; Aline Thomas; Anne Imberty; Romain R Vivès; Timothy Johnson; Aldo Gutierrez; Elisabetta A M Verderio
Journal:  J Biol Chem       Date:  2012-03-22       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.